Though they found more benefits associated with the GLP-1 drugs than risks, study author Dr. Ziyad Al-Aly, who is chief of research and development at the VA St. Louis Health Care System ...
Though they found more benefits associated with the GLP-1 drugs than risks, study author Dr. Ziyad Al-Aly, who is chief of research and development at the VA St. Louis Health Care System ...
First, most of the patients whose records were used for the study were older, white and male, which is typical of the population served by the VA health ... like a road map for future studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback